GGrantIndex
← Leaderboards

Scott A. Handley

Massachusetts General Hospital

$3,542,649
Attributed
$9,610,160
Total exposure
4
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,610,160 · 4

By mechanism

R01$9,610,160 · 4

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Cells

Research focus

CellsMicrobiotaImmuneChronicMicrobialGut MicrobiotaPreventVirus DiseasesMediatingMetagenomicsInfectionInflammationMicrobiomePathogenesisImmune ResponseAffectImmunityInflammatoryAdoptive TransferMouse ModelKnockout MiceGerm-FreeExperimental StudyAntibiotics

Grant awards (15)

Identifying drivers of genital inflammation and HIV acquisition in women living in sub-Saharan Africa$769,000
R01 · FY2025 · AI
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$652,163
R01 · FY2025 · AI
Identifying drivers of genital inflammation and HIV acquisition in women living in sub-Saharan Africa$819,227
R01 · FY2024 · AI
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$657,820
R01 · FY2024 · AI
Systemic Neurotropic virus infection effects on GI Dysmotility$665,032
R01 · FY2023 · DK
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$661,548
R01 · FY2023 · AI
Systemic Neurotropic virus infection effects on GI Dysmotility$688,338
R01 · FY2022 · DK
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$620,348
R01 · FY2022 · AI
Systemic Neurotropic virus infection effects on GI Dysmotility$690,112
R01 · FY2021 · DK
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$624,846
R01 · FY2021 · AI
Systemic Neurotropic virus infection effects on GI Dysmotility$706,017
R01 · FY2020 · DK
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$507,964
R01 · FY2020 · HL
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$509,003
R01 · FY2019 · HL
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$510,008
R01 · FY2018 · HL
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease$528,734
R01 · FY2017 · HL